* Sol Gel Technologies Ltd SLGL.OQ reported a quarterly
adjusted
loss of 1 cent per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -21 cents. The mean expectation of two analysts
for the quarter was for a loss of 13 cents per share. Wall
Street expected results to range from -21 cents to -5 cents per
share.
* Revenue rose 2,416.9% to $5.36 million from a year ago;
analysts
expected $2.69 million.
* Sol Gel Technologies Ltd's reported EPS for the quarter
was a
loss of 1 cent.
* The company reported a quarterly loss of $366 thousand.
* Sol Gel Technologies Ltd shares had fallen by 26.5% this
quarter and lost 54.8% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 36.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Sol Gel
Technologies Ltd is 5.00
This summary was machine generated from LSEG data November 15 at
12:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jan. 1 0001 -0.13 -0.01 Beat
Jun. 30 2024 -0.20 0.07 Beat
Mar. 31 2024 -0.15 -0.23 Missed
Dec. 31 2023 -0.17 -0.17 Met